We are live on ! Find out more
FC

Finepoint Capital Portfolio holdings

AUM $1.95B
1-Year Est. Return 45.61%
This Fund
S&P 500
This Quarter Est. Return
-10.17%
1 Year Est. Return
+45.61%
3 Year Est. Return
+24.83%
5 Year Est. Return
+26.66%
10 Year Est. Return
–
AUM
$1.31B
AUM Growth
-$326M
Cap. Flow
-$191M
Cap. Flow %
-14.59%
Top 10 Hldgs %
94.75%
Holding
26
New
–
Increased
–
Reduced
16
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
LBRDK icon
Liberty Broadband Class C
LBRDK
+$119M
2
ARGX icon
argenx
ARGX
+$32.6M
3
LLYVK icon
Liberty Live Group Series C
LLYVK
+$27.1M
4
QXO
QXO Inc
QXO
+$6.33M
5
SWTX
SpringWorks Therapeutics
SWTX
+$928K

Sector Composition

Rank Sector Weight
1 Industrials 25.27%
2 Healthcare 14.22%
3 Communication Services 5.68%
4 Energy 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$422M 32.2%
755,000
– –
QXO
2
QXO Inc
QXO
$14.9B
$331M 25.27%
24,468,160
-465,665
-2% -$6.33M
IWM icon
3
PUT
iShares Russell 2000 ETF
IWM
$82.2B
$296M 22.59%
1,485,000
– –
LBRDK icon
4
Liberty Broadband Class C
LBRDK
$4.43B
$45M 3.43%
529,240
-1,486,470
-74% -$119M
SWTX
5
DELISTED
SpringWorks Therapeutics
SWTX
$32.2M 2.45%
728,602
-20,150
-3% -$928K
LLYVK icon
6
Liberty Live Group Series C
LLYVK
$9.45B
$29.5M 2.25%
432,895
-379,897
-47% -$27.1M
ASND icon
7
Ascendis Pharma A/S
ASND
$17.1B
$28M 2.14%
179,872
-5,000
-3% -$714K
RVMD icon
8
Revolution Medicines
RVMD
$39.6B
$24.4M 1.86%
691,260
-19,000
-3% -$771K
MLTX icon
9
MoonLake Immunotherapeutics
MLTX
$1.64B
$17M 1.3%
435,785
-12,150
-3% -$524K
LKFT
10
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.97B
$16.5M 1.26%
656,587
-18,175
-3% -$459K
CYTK icon
11
Cytokinetics
CYTK
$10.9B
$12.5M 0.95%
309,948
-8,500
-3% -$391K
RNAM
12
DELISTED
Avidity Biosciences
RNAM
$11.2M 0.86%
380,700
-10,600
-3% -$330K
SRPT icon
13
Sarepta Therapeutics
SRPT
$1.82B
$10.1M 0.77%
157,555
-4,380
-3% -$461K
PRTA icon
14
Prothena Corp
PRTA
$453M
$7.92M 0.6%
640,071
-17,000
-3% -$240K
XNCR icon
15
Xencor
XNCR
$1.3B
$6.83M 0.52%
642,200
-17,800
-3% -$294K
EYPT icon
16
EyePoint Inc
EYPT
$1.12B
$5.86M 0.45%
1,081,954
-29,150
-3% -$204K
RLAY icon
17
Relay Therapeutics
RLAY
$4.34B
$5.55M 0.42%
2,117,646
-58,000
-3% -$227K
ARVN icon
18
Arvinas
ARVN
$517M
$4.87M 0.37%
694,028
-19,750
-3% -$309K
SLDB icon
19
Solid Biosciences
SLDB
$858M
$3.56M 0.27%
961,251
– –
ANNA
20
AleAnna Inc
ANNA
$141M
$209K 0.02%
27,717
– –
ANNAW
21
AleAnna Inc Warrant
ANNAW
$12.5M
$122K 0.01%
490,000
– –
GATEW
22
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
$118K 0.01%
735,000
– –
MNYWW
23
MoneyHero Ltd Warrants
MNYWW
$32.8K ﹤0.01%
895,000
– –
LSBPW
24
DELISTED
LakeShore Biopharma Warrants
LSBPW
$20.2K ﹤0.01%
489,999
– –
CLDI icon
25
Calidi Biotherapeutics
CLDI
$2.3M
$7.08K ﹤0.01%
1,042
– –
1
2

Similar funds

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $1.94B AUM 25.76% 1-Year Est. Return
MWA
Midland Wealth Advisors Effingham, Illinois $1.94B AUM 14.31% 1-Year Est. Return

Finepoint Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Finepoint Capital held 26 positions worth $1.31B, down 20% from $1.64B the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Finepoint Capital withdrew a net $191M in Q1 2025, closing 1 position and reducing 16 holdings. Its most notable exit was argenx, an estimated $32.6M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Communication Services.

  • Finepoint Capital's biggest Q1 2025 reduction was Liberty Broadband Class C, cutting an estimated $119M.
  • Finepoint Capital fully exited argenx in Q1 2025, selling an estimated $32.6M.
  • Finepoint Capital's ten largest holdings make up 95% of its $1.31B portfolio in Q1 2025.
  • Finepoint Capital opened 0 new positions and closed 1 in Q1 2025.
  • Finepoint Capital's portfolio value fell 20% quarter-over-quarter to $1.31B.

Based on Finepoint Capital's 13F filing for Q1 2025, filed 14 May 2025.